Trials / Recruiting
RecruitingNCT06288204
Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease
Association of Green Propolis Extract and Royal Jelly to Modulate Inflammation and Oxidative Stress in Hypertensive Patients and/or With Chronic Kidney Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 153 (estimated)
- Sponsor
- Universidade Federal Fluminense · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This work aims to evaluate the effects of the association of green propolis extract with royal jelly on inflammation and oxidative stress in participants with chronic kidney diseases (CKD) and Systemic arterial hypertension (SAH), in a longitudinal, randomized, double-blind, placebo-controlled clinical trial that will be carried out for 2 months.
Detailed description
Propolis and royal jelly are bee products. Propolis is a resinous mixture produced by bees with their saliva and the addition of wax, from exudates collected from buds and plant sap. Royal jelly is a substance produced in the hypopharyngeal glands of young worker bees. Both products are rich in bioactive compounds such as polyphenols. The combination of propolis extract and royal jelly, substances constituted by the combination of several chemical components with potential biological activity, may emerge as a promising adjuvant therapeutic alternative for patients with CKD and SAH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Propolis associated with Royal Jelly | The participants will consume 4 capsules a day, providing daily royal jelly in an amount of 100 mg/day plus 500 mg/day of propolis together, for 2 months. |
| DIETARY_SUPPLEMENT | Royal Jelly | The participants will consume 1 capsules a day, providing daily royal jelly in an amount of 100 mg/day, for 2 months. |
| DIETARY_SUPPLEMENT | Placebo | The participant will consume 4 capsules a day of placebo, for 2 months. |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-07-31
- Completion
- 2027-07-31
- First posted
- 2024-03-01
- Last updated
- 2025-04-04
Locations
2 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT06288204. Inclusion in this directory is not an endorsement.